Research on the Comparison and Development Countermeasures of Pharmaceutical Group Purchasing Modes from the Perspective of the Normalization of National Centralized Procurement

Corresponding author: Zhao Ke, zhaoke0621@163.com

DOI: 10.12201/bmr.202109.00037

•  

  Abstract: Pharmaceutical group procurement is a typical mode of centralized drug procurement in China. The coordinated development with the normal operation of national centralized procurement is of great significance to the establishment of a national drug market-oriented procurement system. By analyzing the development status of domestic drug group procurement models, it compares and analyzes the differences between national drug centralized procurement and drug group procurement from four aspects: management mechanism, price strategy, market competition, and procurement rules, focusing on regulatory mechanisms and service functions. Market competition and coordinated development, discussed the future development challenges of domestic drug group procurement, and gave corresponding development countermeasures. The research results can provide assistance for optimizing the procurement management practice of pharmaceutical groups and promoting the high-quality coordinated development of centralized procurement of drugs.

  Key words: Centralized procurement of drugs; Pharmaceutical Group Procurement; Normalize; Coordinated development

  Submit time: 21 December 2021

  Copyright: The copyright holder for this preprint is the author/funder, who has granted biomedRxiv a license to display the preprint in perpetuity.
• html

• 图表

• ZENGXUHENG, ZHENGJI, LVJUN, NINGYULING, LIXIAOHONG. SWOT analysis on volume-based procurement of high-value medical consumables: A case of Shanghai. 2020. doi: 10.12201/bmr.202010.00841

  HAN You-li, CUI Ji-yu. Research on the development strategies of new antineoplastic agents: An analysis based on the comparison of new drugs launched in China, America and Japan. 2021. doi: 10.12201/bmr.202106.00021

  CHEN Tong, JIANG Rong, SHAO Rong. Research and Enlightenment on Canadian Pharmaceutical Rebates Agreements. 2021. doi: 10.12201/bmr.202101.00019

  tan min, su dai, zhang yunfan, lei shihan, chen yingchun. Quantitative Research on the Coordinated Development of Social Economy and Health Resources——Based on Panel data of 31 Provinces (Cities) from 2010 to 2018. 2021. doi: 10.12201/bmr.202007.00028

  Li Hong-yu, Sun Qiang. Analysis of the impact of the Two Ballot System policy on drug supply in Shandong province. 2021. doi: 10.12201/bmr.202011.00015

  Jiang Rong, Chen Tong, Shao Rong. JIANG Rong, CHEN Tong, SHAO Rong*. 2020. doi: 10.12201/bmr.202007.00023

  Jiang Xiao-juan, Xiao De-wen. Discussion on Hospital Information Construction Under the Background of Normalized Epidemic Prevention and Control. 2020. doi: 10.12201/bmr.202008.00019

  Zhang Chunyang, Hu Hongwei. Research on the prediction mechanism of working ability of elderly nursing staff based on neural network: Perspective of professionalization. 2021. doi: 10.12201/bmr.202104.00022

  LIU Xi, DENG Meng, LIU Wei, PAN Yuan, XU Ting-ting, Feng Qi-ming, ZHAO jin-min. Research on the Policy Texts of National Essential Medicine System from 2009 to 2020. 2021. doi: 10.12201/bmr.202105.00010

  lifeiteng, Yangxiaoyan. An analysis of the development status and problems of mobile health APPs from the perspective of public health. 2020. doi: 10.12201/bmr.202005.00247

• ID	Submit time	Number	Download
  1	2021-09-01	bmr.202109.00037V1	Download

• Public  Anonymous  To author only Submit Comments